NeoPath and AutoCyte work towards combining cervical smear devices
This article was originally published in Clinica
Executive Summary
NeoPath and AutoCyte have formed a partnership aimed at combining NeoPath's artificial intelligence-based Pap smear detection device, AutoPap, with AutoCyte's PREP monolayer slide preparation and staining system used to detect cervical cell abnormalities.